Authors

• Lindsey Powers Happ (ORCID: https://orcid.org/0000-0002-6782-1618)
• Ana Urosevic
• Malin L. Hultcrantz (ORCID: https://orcid.org/0000-0002-9045-6495)
• François Laliberté (ORCID: https://orcid.org/0000-0003-2601-6214)
• Ravi Vij (ORCID: https://orcid.org/0000-0001-8795-3610)
• Fernando Escalante (ORCID: https://orcid.org/0000-0003-4501-9066)
• Leena Camadoo-O'Byrne
• Natalie Boytsov
• Malena Mahendran
• Hans Chulhee Lee (ORCID: https://orcid.org/0000-0001-8545-3292)
• Guillaume Germain (ORCID: https://orcid.org/0000-0002-4525-7673)
• Jacopo Bitetti
• Mei Sheng Duh (ORCID: https://orcid.org/0000-0001-5035-6687)
• David Kleinman (ORCID: https://orcid.org/0000-0002-1311-5216)
• Michèle Cavo (ORCID: https://orcid.org/0000-0003-4514-3227)
• Nirali Kotowsky
• Michel Delforge

Institutions

• Memorial Sloan Kettering Cancer Center (US)
• The University of Texas MD Anderson Cancer Center (US)
• Providence College (US)
• Washington University in St. Louis (US)
• Age UK (GB)
• University of Rochester Medical Center (US)
• Istituto di Ematologia di Bologna (IT)
• Group for Research in Decision Analysis (CA)
• Hospital Universitario de León (ES)
• Analysis Group (United States) (US)
• KU Leuven (BE)

Publication Details

Journal

Haematologica

Published

2024-10-17

DOI

https://doi.org/10.3324/haematol.2024.285893

Primary Topic

Multiple Myeloma Research and Treatments

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Memorial Sloan-Kettering Cancer Center